Evidence map›Paper›PMID 37877627›Full record

ArticleEmerging infectious diseases2023

Hepatitis C Virus Elimination Program among Prison Inmates, Israel.

Lihi Eisen, Zohar Mor, Miriam Madar, Ron Rabinovitch, Yuval Dadon, Rivka Sheffer, Ehud Kaliner, Liav Goldstein

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lihi Eisen
Zohar Mor
Miriam Madar
Ron Rabinovitch
Yuval Dadon
Rivka Sheffer
Ehud Kaliner
Liav Goldstein

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Israeli Prison Services implemented a hepatitis C virus (HCV) elimination program in 2020. Inmates considered high risk for HCV were offered serology; HCV-seropositive participants were offered HCV RNA testing. Among participants, 7.0% had detectable HCV RNA and were offered antiviral drug therapy. This program reduced HCV burden among incarcerated persons.

Indexed as

Hepatitis CPrisonersHepacivirusHumansIsraelPrisonsRNARNAcorrectional facilitiesdrug usersHCVHepatitis Chepatitis C virusIsraelprisonersscreeningtreatmentviruses

Identifiers

PMID37877627
PMCPMC10617329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.